ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Isorhamnetin ameliorates active ulcerative colitis potentially involving the Nrf2-PTGS2 axis: an integrative study from clinical evidence mining to in vivo validation.
Zhenjia Fan et al.PubMed ↗Publisher ↗
No numbers read from the abstract.